This is the first study to look at carotid atherosclerotic plaque histological features in patients having surgery in the acute and hyperacute period and comparing presence of 'unstable' features to plaques from patients undergoing delayed surgery. As might be expected plaques from patients in the hyperacute and acute period showed high prevalence of unstable features. These features tend to stabilise over a period of four weeks, but then re-occur after this period, suggesting a secondary phase of instability.
INTRODUCTION
Natural history studies have shown that the early risk of stroke after TIA/minor stroke is significantly higher than was previously thought. 1, 2 This, in conjunction with awareness that carotid endarterectomy (CEA) confers greater benefit if performed as soon as possible, has led to the current drive towards performing CEA in the hyperacute period after onset of symptoms. It is assumed that the higher risk of early stroke is associated with a highly unstable carotid plaque with overlying surface disruption and thrombus formation. Previous studies 3e6 have correlated histological features from resected carotid atherosclerotic plaques following CEA, however few have analysed plaque histology in the very early time period after onset of symptoms (e.g. first 7 days).
The aim of the current study was to test the hypothesis that patients undergoing CEA within the hyperacute period after onset of symptoms would exhibit a greater prevalence of unstable histological plaque features 7 that would then diminish with time.
METHODS
The study was authorised by the Leicestershire, Northamptonshire and Rutland Ethics Committee and patients were entered after giving informed consent.
Patient selection
All recently symptomatic patients with a >50% NASCET extra-cranial carotid artery stenosis who were admitted to the Leicester Vascular Surgery unit for CEA were considered for inclusion. All had been referred via a consultant Stroke Physician (mostly via the rapid access TIA Clinic which was established in October 2008). 8 Our aim was to offer CEA as soon as possible after onset of symptoms. However, a proportion of patients were referred after 14 days had elapsed.
As a baseline for comparison all asymptomatic patients undergoing CEA in our unit were also recruited into the study for comparison.
In the TIA Clinic, the consultant Stroke Physician took responsibility for optimising risk factors. Each patient was commenced on statin therapy (Simvastatin 40 mg daily), antiplatelet therapy (300 mg loading doses of Aspirin plus 200 mg Dipyridamole) followed by Aspirin 75 mg daily. In addition 75 mg clopidogrel was given the night before surgery 9 and antihypertensive therapy was modified/introduced as appropriate.
Data collection
Pre-operative clinical data were recorded by a single investigator (MS) through face to face questioning of patients and after review of medical notes and in-patient investigations. Demographic data included; age, sex, vascular risk factors (hypertension, hyperlipidaemia, diabetes mellitus and smoking), pre-operative medication and time from index event and most recent event.
Carotid endarterectomy
Carotid surgery was performed under general anaesthesia with routine patching, routine shunting, systemic heparinisation (unfractionated) and distal intimal tacking sutures. 10 Endarterectomy was performed via a linear arteriotomy and the plaque removed with the minimum of trauma possible.
Histopathology
Plaques harvested during CEA (Figs. 1 and 2) were divided longitudinally and one half randomly fixed immediately in formalin for 24 h and then paraffin embedded. A 5 mm transverse section was taken from the paraffin block and stained using haematoxylin and eosin. Histological specimens were analysed by two independent Histopathologists (KW, DM) who were blinded to the clinical data.
For each plaque, a semi-quantitative 3 or 4 point score (Table 1 ) was assigned to show the presence and/or amount of features of plaque instability based on the AHA histological classification of advanced atherosclerotic lesions 7 and a well validated previously published scoring system. 11 Features analysed included; intra-plaque haemorrhage, lipid core size, chronic plaque inflammatory infiltrate, chronic cap inflammatory infiltrate, neovascularity, amount of foam cells, and evidence of cap rupture. Intra-plaque haemorrhage was defined as evidence of erythrocytes within the plaque causing disruption of plaque architecture as defined by Bassiouny.
12 Lipid core was defined as an area of amorphous material containing cholesterol clefts. Rupture was defined as a clear communication between lipid core and lumen with a break in the fibrous cap. A grade of 2 or 3 for each of these features demonstrated histological instability. 
Statistical analysis
T-Test and c 2 was used to compare baseline characteristics between patients in each group. Statistical analysis was performed using SPSS v16 (Chicago, USA).
RESULTS
Between August 2008 and December 2010 232 patients were recruited into the study. 32 patients were excluded from the study as histological data could not be obtained. Two hundred patients were included in the study (121 TIA patients, 38 Stroke patients, 41 Asymptomatic).
Seventy six patients (48%) underwent surgery within seven days of suffering their most recent clinical event, 43 (27%) within 8e14 days, 17 (11%) within 15e28 days, while >29 days had elapsed in 23 patients (14%). This, therefore, provided a broad spectrum of patients with regard to delays to surgery ranging from the acute period (<14 days, n ¼ 119), intermediate (15e28 days, n ¼ 17) and late (>29 days, n ¼ 23).
Demographic data for patients in the study stratified by timing and delays to surgery are shown in Table 2 . All groups were matched for age, sex and vascular risk factors.
The number of histologically unstable features identified in each plaque stratified according to the delay to surgery from most recent ischaemic event is shown in Table 3 . In patients in the acute group (symptoms within 14 days) 87/119 (73%) had 5 or more unstable features detected in their plaque. In comparison in patients who underwent delayed surgery only 22/40 (55%) had 5 or more unstable features (P ¼ 0.04). As a baseline comparison only 9/41 (22%) asymptomatic patients had 5 or more unstable features compared to the 109/159 (69%) of all symptomatic patients (OR 7.8 95% CI 3.442e17.4546 P < 0.0001).
The prevalence of each individual histologically unstable feature stratified by timing and delay to surgery are shown in Table 4 . There is a sustained decline in the number of histologically unstable features detected in the 136 patients undergoing delayed surgery between <7 days, 8e14 days and 15e28 days. However there was then an upsurge in 6 of the7 unstable features in patients who underwent delayed surgery >28 days from the most event, compared to those operated on within 15e28 days from most event. Only chronic cap inflammation continued to show a sustained decline. Notably; a large lipid core significantly increased from 7/17 (41%) at 15e28 days compared with 18/23 (78%) in patients undergoing surgery after >28 days had elapsed (P ¼ 0.02). As a baseline comparison, when looking at individual features in the asymptomatic group all features showed lower prevalence than in the symptomatic group and except for cap rupture lower than in the delayed presentation group.
The prevalence of each individual histologically unstable feature stratified by timing and delay to surgery and by symptom status is shown in Table 5 . A similar trend is seen in both patients who have TIAs and strokes as their presenting symptom with a sustained decline in the number of histologically unstable features detected in patients undergoing delayed surgery between <7 days, 8e14 days and 15e28 Table 2 . Demographics for all symptomatic patients grouped by time delay to surgery. Table 6 . In patients who had delayed presentation (>28 days from most recent event to CEA (n ¼ 23)), 15/23 (65%) had experienced just a single event, whilst 8/23 (35%) described two or more events. Notably marked neovascularity was noted to rise significantly in the delayed group in patients who had multiple events.
DISCUSSION
A number of studies have correlated plaque histology with symptom status, 3e6 risk of recurrent ischaemic events 13 and (more recently) with delays from onset of symptoms to surgery. 14, 15 Few, however, have included a sufficiently large number of patients undergoing CEA in the hyperacute period after onset of symptoms. Our study is, therefore, one of the first to look at standardised histologically verified unstable features in plaques taken from patients undergoing surgery at various points from the most recent ischaemic event, including a large proportion in the hyperacute period (symptoms <7 days).
In the current series, 76% of symptomatic patients underwent surgery within 14 days of their most recent event and 73% demonstrated 5 or more highly unstable histological features. This was statistically greater than the 55% of patients who underwent delayed surgery (P ¼ 0.048), adding weight to the hypothesis that the early period after onset of symptoms remains a high risk time.
To date the largest most comprehensive study of carotid plaque histology in relation to timing from clinical event was performed by Redgrave et al.
14 526 recently symptomatic patients undergoing carotid endarterectomy had their plaques analysed for histological features using the same semi quantitative score as was used in this paper. Symptomatic patients were classed according to aetiology of ischaemic event; Stroke or TIA. Time since most recent event was divided according to the following periods; 0e30 days, 31e90 days, 91e180 days and >180 days. In patients presenting with a stroke; plaque inflammation, plaque macrophages, cap rupture and unstable features showed a strong decline from the time of stroke out to 180 days. However, a similar trend was not observed in TIA patients. Overall they observed that in TIA patients' features of plaque instability persisted, suggesting a more chronic course of inflammation whilst in stroke patients the features of instability reduced with time suggesting a more acute event. In our study when we stratified for type of ischaemic event and timing from surgery we found that intraplaque haemorrhage, large lipid core, chronic plaque inflammation, marked neovascularity and many foam cells showed similar decline and then upsurge in stroke and TIA patients. Chronic cap inflammation continued to decline in both groups. Only cap rupture showed any difference between cohorts based upon type of event, whereby TIA patients in the delayed group had an upsurge in the prevalence of cap rupture whilst this was seen to continue to fall in the stroke cohort. Peeters et al. 14 evaluated the plaques of 804 patients (Stroke ¼ 204, TIA ¼ 426, Asymptomatic ¼ 174) undergoing carotid endarterectomy and assessed plaque histology in relation to timing between most recent event and surgery. Time periods used in the study were identical to the Oxford study. Peeters showed that in patients who presented with a stroke, macrophage staining decreased nearly two-fold over time, with levels in the >180 day group similar to that observed in asymptomatic patients. They also found smooth muscle cell (SMC) levels rose over time, again reaching levels similar to asymptomatic patients in the group presenting after 180 days. Interestingly; Peeters showed that in patients presenting with a stroke and TIA, the percentage of plaques having a large lipid core increased in those patients who had the greater delay before surgery; i.e. very similar to the findings in the Leicester study.
In comparison to the two studies mentioned above our study aimed to focus on the first 30 days after an ischaemic event and to look at changes in this period. We had a relatively larger cohort of patients in the hyperacute period and smaller numbers in the following groups, however this reflects accurately the case load of patients presenting for CEA in our unit. Asymptomatic patients have been included but only for comparison as a baseline. The highly significant p trend values for each individual unstable feature shown in Table 4 is a reflection of including asymptomatic patients in the analysis.
As expected, the current study showed that there was a sustained decline (with time over the first 28 days) in the prevalence of intraplaque haemorrhage, large lipid core, chronic plaque inflammation, large number of foam cells, marked vascularity and cap rupture. Chronic cap inflammation showed a small increase in prevalence from the hyperacute period (45%) to the acute period (49%), before continuing to decline in those delayed between 15 and 28 days and >28 days. These features are what one might have expected based on previous studies.
However, all six features of plaque instability (intraplaque haemorrhage, large lipid core, chronic plaque inflammation, large number of foam cells, marked vascularity and cap rupture) which had initially showed a sustained decline in prevalence out to day 28, were then noted to increase in prevalence in patients who underwent surgery after 29 days had elapsed. This was most obvious when looking at large lipid core, where the prevalence increased from 41% to 78% prevalence (P ¼ 0.02).
We do not believe there has been a selection bias in the patients referred for delayed CEA in having more unstable features as the majority of these patients 15/23 (65%) presented with just a single event and no significant difference was seen in the type of unstable features and number of unstable features seen ( 19 In patients who have a delayed CEA, it may be that either best medical therapy was not commenced (many patients in the delayed group had delayed presentation) or patients had poor compliance with medication, leading to a secondary increase in the prevalence of unstable histological features. It could also mean that the introduction of antiplatelet and statin therapy has meant that these patients with unstable histological features have remained asymptomatic. These findings may also reflect normal plaque progression whereby in the hyperacute period, there is a vulnerable large lipid core and plaque rupture, followed by discharge of the large lipid core (showing a decrease in plaques with this feature in the 8e28 days group) and then secondary re-accumulation of the lipid core thereafter.
The limitations of this study include; 1. Not having sufficient details on the duration of use of aspirin and statin therapy prior to CEA for patients in each group; 2. Having approximately 14% of the samples of all patients recruited not available for analysis, though we have been able to establish that approximately even numbers from each group were missing and therefore sample sizes were unchanged; 3. The relatively small numbers of patients in the delayed group, which is a result of changing practice to expedite wherever possible intervention for symptomatic patients.
In conclusion this study has shown that plaques excised from patients in the hyperacute period demonstrate the greatest number of unstable features. Unstable plaque features diminished with time (out to 28 days), but then increased. It is, as yet, unclear as to the clinical significance of this phenomenon. Further work can be focussed on establishing the cause of these changes and using imaging techniques to identify patients with delayed presentation who may have unstable plaques.
